SciELO - Scientific Electronic Library Online

 
vol.84 issue2Training and clinical activity of spanish retinologists: A preliminary approach: Retina 2 project. Descriptive analysisEnzymatic vitrectomy by intravitreal autologous plasmin injection as initial treatment for macular epiretinal membranes and vitreomacular traction syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos de la Sociedad Española de Oftalmología

Print version ISSN 0365-6691

Abstract

DIEZ, M.R. et al. Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years’ experience. Arch Soc Esp Oftalmol [online]. 2009, vol.84, n.2, pp.85-90. ISSN 0365-6691.

Purpose: To present the outcomes of prophylaxis of postoperative endophthalmitis following cataract surgery with intracameral Cefuroxime. Method: A retrospective study was done on 4281 eyes that underwent cataract surgery from October 2003 to September 2008. All patients underwent phacoemulsification cataract surgery. All cases received an injection of 0.1 ml intracameral Cefuroxime (1 mg) at the end of surgery except those patients allergic to penicillin and cephalosporin until September 2007 and thereafter only those with demonstrated allergy to cefuroxime. Results: The rate of postoperative endophthalmitis was 0.11% (5 cases). Four of them had a positive culture. We found no evidence of clinical ocular toxicity. Conclusions: Intracameral cefuroxime works very well for reducing the incidence of postoperative endophthalmitis. It appears safe to use and is easy to prepare.

Keywords : Postoperative endophthalmitis; cataract; phacoemulsification; cefuroxime; prophylaxis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License